Gastrointestinal Cancer

The Pharmacy Times® Gastrointestinal Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur in digestive tract organs, such as the stomach, large and small intestine, pancreas, colon, liver, rectum, anus, and biliary system.

Latest News

Image Credit: © Crystal light - stock.adobe.com
Zolbetuximab-clzb Receives FDA Approval for Treatment of Advanced Gastric and GEJ Adenocarcinoma

October 18th 2024

Zolbetuximab is the first approved CLDN18.2-targeted treatment for gastric and gastroesophageal junction adenocarcinoma.

B-cell, white blood cell 3D, type of lymphocyte interacting with a virus. Adaptive immune response, CAR-T cell therapy.
Atezolizumab and Hyaluronidase-tqjs Subcutaneous Formulation Receives FDA Approval to Treat Multiple Forms of Cancer

September 13th 2024

Close up of a cancer cell under a microscope
FDA Accepts Biologics License Application For Nivolumab Plus Ipilimumab to Treat Hepatocellular Carcinoma

August 22nd 2024

3D illustration of pancreatic cancer.
Avutometinib With Defactinib Granted FDA Orphan Drug Designation to Treat Pancreatic Cancer

July 30th 2024

Illustration of the digestive system emphasizing the pancreas and gallbladder. Concept Human Anatomy, Digestive System, Physiology, Pancreas, Gallbladder - Image credit: Ян Заболотний | stock.adobe.com
FDA Grants Priority Review for Zanidatamab to Treat HER2-Positive Metastatic Biliary Tract Cancer

May 30th 2024

Latest CME Events & Activities

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

<123